Finance

Lists
Q3 2026 earnings • released • EPS beat +26.60% • Revenue beat +3.54%
See results
CVSH34:BVMF
Cvs Health Corporation BDR
R$44.16
0.00%
(0.00) 1D
Nov 5, 10:32:23 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for CVSH34...
Open
R$43.84
High
R$44.16
Low
R$43.75
Mkt. cap
104.02B
Avg. vol.
338.00
Volume
0.00
52-wk high
R$57.84
52-wk low
R$36.24
Shares outstanding
1.28B
No. of employees
260K
Open
R$43.84
High
R$44.16
Low
R$43.75
Mkt. cap
104.02B
Avg. vol.
338.00
Volume
0.00
52-wk high
R$57.84
52-wk low
R$36.24
Shares outstanding
1.28B
No. of employees
260K
News stories
From web sources and news partners
Profile
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores. On November 4, 2026, CVS announced that they will split into two companies, making it the largest split in the healthcare business. Wikipedia
About Cvs Health Corporation BDR
CEODavid Joyner
Employees260K
Founded1963
HeadquartersWoonsocket, Rhode Island, United States
SectorHealth Care
IndustryHealth care provider
Websitecvshealth.com
Last report
Nov 4, 2026
Fiscal period
Q3 2026
$2.09 / $1.65
+26.60%beat
Revenue / Est. (USD)
108.40B / 104.69B
+3.54%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
105.10B
99.85B
105.46B
108.40B
Cost of goods sold
92.13B
84.80B
90.35B
93.50B
Cost of revenue
92.13B
84.80B
90.35B
93.50B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.32B
10.93B
11.04B
11.33B
Operating expense
11.32B
10.93B
11.04B
11.33B
Total operating expenses
103.45B
95.73B
101.38B
104.83B
Operating income
1.65B
4.12B
4.07B
3.57B
Other non operating income
-88.00M
32.00M
31.00M
30.00M
EBT including unusual items
1.35B
3.94B
3.98B
2.85B
EBT excluding unusual items
1.37B
3.95B
3.99B
2.85B
Income tax expense
-1.57B
981.00M
982.00M
678.00M
Effective tax rate
-115.88%
24.91%
24.69%
23.80%
Other operating expenses
-
-
-
-
Net income
2.94B
2.94B
2.98B
2.17B
Net profit margin
2.80%
2.95%
2.82%
2.00%
Earnings per share
1.09
2.57
2.58
2.09
Interest and investment income
594.00M
574.00M
641.00M
-
Interest expense
-787.00M
-774.00M
-757.00M
-747.00M
Net interest expenses
-193.00M
-200.00M
-116.00M
-747.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.80B
5.23B
5.20B
4.70B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps